Association between oxidative damage markers and self-reported temporomandibular dysfunction symptoms in patients with chronic fatigue syndrome

Journal of Chronic Fatigue Syndrome

Volumn 12, Issue 3, 2004, Pages 45-61

  Richards, Ross S ^a   McGregor, Neil R ^b,c   Roberts, Timothy K ^d  

^a CHARLES STURT UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Chronic fatigue syndrome; Malondialdehyde; Methemoglobin; Oxidative damage; Pain aetiology; TMD aetiology; TMD syndrome; Vitamin b12

Indexed keywords

C REACTIVE PROTEIN; CYANOCOBALAMIN; FERRITIN; MALONALDEHYDE; METHEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JAW MUSCLE; MALE; MULTIPLE REGRESSION; MYALGIA; OXIDATIVE STRESS; PREVALENCE; SCHOOL CHILD; SELF REPORT; SYMPTOMATOLOGY; TEMPOROMANDIBULAR JOINT DISORDER;

EID: 28844481022     PISSN: 10573321     EISSN: None     Source Type: Journal    
DOI: 10.1300/J092v12n03_04     Document Type: Article

References (29)

1. Pullinger AG, Seligman DA, Solberg WK. Temporomandibular disorders. Part 1: Functional status, dentomorphological features and sex differences in a non-patient population. J Prosthet Dent 1988; 59:228-235.
2. Kleinknecht PA, Alexander LD, Mahoney ER, Dworkin SF. Correspondence between subjective report of temporomandibular disorder symptoms and clinical findings. J Am Dent Ass 1986; 113:257-261.
3. Plesh O, Wolf F, Lane N. The relationship between fibromyalgia and temporomandibular disorders: Prevalence and symptom severity. J Rheumatol 1996; 23: 1948-1952.
4. McGregor NR, Butt HL, Zerbes M, Klineberg IJ, Dunstan RH, Roberts TK. Assessment of pain (distribution and onset), symptoms, SCL-90-R inventory responses and the association with infectious events in patients with orofacial pain. J Orofacial Pain 1996; 10:339-350.
5. Fricton JR, Kroening R, Haley D, Siegert R. Myofacial pain syndrome of the head and neck: A review of clinical characteristics of 164 patients. Oral Surg Oral Med Oral Pathol 1985; 60:615-619.
6. Richards RS, Roberts TK, Mathers D, Dunstan RH, McGregor NR, Butt HL. Erythrocyte morphology in rheumatoid arthritis and chronic fatigue syndrome: A preliminary study. J Chronic Fatigue Synd 2000; 6:23-35.
7. Richards RS, Roberts TK, Mathers D, Dunstan RH, McGregor NR, Butt HL. Investigation of erythrocyte oxidative damage in rheumatoid arthritis and chronic fatigue syndrome. J Chronic Fatigue Synd 2000: 6:37-46.
8. Richards RS, Roberts TK, Mathers D, Dunstan RH, McGregor NR, Butt HL. Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Report 2000: 5(1):35-41.
9. Aghabeigi B, Haque M, Wasil M, Hodges SJ, Henderson B, Harris M. The role of oxygen free radicals in idiopathic facial pain. Brit J Oral Max Surg 1997; 35:161-5.
10. Holmes G, Kaplan J, Gantz N, et al. Chronic fatigue syndrome: a working case definition. Ann Int Med 1988; 108:387-389.
11. Sharpe MC, Archard LC, Banatvala JE, et al. A report-chronic fatigue syndrome: guidelines for research. J Roy Soc Med 1991; 84:118-121.
12. Jaffe ER. Methaemoglobin pathophysiology. Prog Clin Biol Res 1981; 51: 133-151.
13. Clopton DA, Saltman P. Copper-specific damage in human erythrocytes exposed to oxidative stress. Biol Trace Ele Res 1997; 56:231-240.
14. Dotsch J, Demirakca S, Cryer A, Hanze J, Kuhl PG, Rascher W. Reduction of NO-induced methaemoglobinemia requires extremely high doses of ascorbic acid in vitro. Int Care Med 1998; 24 (6):612-615.
15. Kaca W, Roth RI, Vangegriff KD, et al. Effects of bacterial endotoxin on human cross-linked and native haemoglobins. Biochem 1995; 34:11176-11185.
16. Pirmohamed M, Coleman MD, Hussain F, Breckenridge AM, Park BK. Direct and metabolism dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes. Brit J Clin Pharmacol 1991; 32:303-310.
17. Sullivan SG, Stern A. Effects of physiologic concentrations of lactate, pyruvate and ascorbate on glucose metabolism in unstressed and oxidatively stressed human red blood cells. Biochem Pharmacol 1983; 32:2891.
18. LeResche L, Fricton J, Mohl N, et al. Research diagnostic criteria. Part II. J Cranio Dis Fac Oral Pain 1992; 6:327-334.
19. Butt HL, Dunstan RH, McGregor NR, Roberts TK, Zerbes M, Klineberg IJ. An association of membrane-damaging toxins from coagulase-negative staphylococci and chronic orofacial muscle pain. J Med Microbiol 1998; 47:577-584.
20. Hickie I, Lloyd A, Wakefield D, Ricci C. Is there a postinfection fatigue syndrome? Aust Fam Physician 1996; 25:1847-1852.
21. Klimas N. Pathogenesis of chronic fatigue syndrome and fibromyalgia. Growth Horm IGF Res 1998; 8 Suppl B:123-126.
22. Komaroff AL. Chronic "post-infectious" fatigue syndrome. Trans Am Acad Insur Med 1993; 76:82-95.
23. Mawle AC, Reyes M, Schmid DS. Is chronic fatigue syndrome an infectious disease? Infect Agents Dis 1993; 2:333-341.
24. Abbey SE, Garfinkel PE. Neurasthenia and chronic fatigue syndrome: the role of culture in the making of a diagnosis. Am J Psychiatry 1991; 148:1638-1646.
25. Evans AS. Chronic fatigue syndrome: thoughts on pathogenesis. Rev Infect Dis 1991; 13 Suppl 1:856-859.
26. Farmer A, Jones I, Hillier J et al. Neuraesthenia revisited: ICD-10 and DSM-III-R psychiatric syndromes in chronic fatigue patients and comparison subjects. Br J Psychiatry 1995; 167:503-506.
27. Hickie IB, Davenport TA, Hadzi-Pavlovic D et al. Development of a simple screening tool for common mental disorders in general practice. Med J Aust 2001; 175 Suppl:S10-S17.
28. Nasralla M, Haier J, Nicolson GL. Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia syndrome. Eur J Clin Microbiol Infect Dis 1999; 18:859-865.
29. Nijs J, Nicolson GL, De Becker P et al. High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients. FEMS Immunol Med Microbiol 2002; 34:209-214.